$NHHS
NorthStar Healthcare Income, Inc.

2020 Q4 Form 10-Q Financial Statement

#000150370720000033 Filed on November 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $66.84M $67.14M $72.78M
YoY Change -8.32% -7.74% -0.94%
Cost Of Revenue $46.65M $46.50M $45.36M
YoY Change 1.41% 2.52% -4.21%
Gross Profit $20.19M $20.64M $27.42M
YoY Change -24.95% -24.72% 4.99%
Gross Profit Margin 30.21% 30.74% 37.67%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $15.95M $16.16M
YoY Change -1.35% -36.93%
% of Gross Profit 77.25% 58.95%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $16.46M $17.22M
YoY Change -4.41% -2.6%
% of Operating Profit
Other Income/Expense, Net $612.0K
YoY Change
Pretax Income -$17.10M -$11.64M
YoY Change 46.87% -50.01%
Income Tax $15.00K $17.00K
% Of Pretax Income
Net Earnings -$93.54M -$18.16M -$14.62M
YoY Change 252.0% 24.17% 121.44%
Net Earnings / Revenue -139.94% -27.04% -20.09%
Basic Earnings Per Share -$0.09
Diluted Earnings Per Share -$0.09
COMMON SHARES
Basic Shares Outstanding 190.2M shares 189.8M shares 189.0M shares
Diluted Shares Outstanding 189.8M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $66.00M $72.31M $29.18M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $21.39M $21.39M $21.39M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $229.2M $230.3M $282.6M
YoY Change -14.77% -18.51%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.918B $2.008B $2.173B
YoY Change -10.4% -7.6% -7.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $1.506B $1.506B $1.480B
YoY Change 2.22% 1.77% -2.57%
SHAREHOLDERS EQUITY
Retained Earnings -$1.303B -$1.211B -$1.015B
YoY Change 25.11% 19.35% 17.21%
Common Stock $1.712B $1.710B $1.705B
YoY Change 0.46% 0.28% 0.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $409.6M $497.9M $687.9M
YoY Change
Total Liabilities & Shareholders Equity $1.918B $2.008B $2.173B
YoY Change -10.4% -7.6% -7.53%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$93.54M -$18.16M -$14.62M
YoY Change 252.0% 24.17% 121.44%
Depreciation, Depletion And Amortization $15.95M $16.16M
YoY Change -1.35% -36.93%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
NorthStar Healthcare Income, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001503707
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
190153995 shares
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2020Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
0 USD
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Shell Company
EntityShellCompany
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
190020662 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
189111561 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
190020662 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
189111561 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
190153995 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72305000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41884000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
26504000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
16936000 USD
CY2020Q3 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1571696000 USD
CY2019Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1700218000 USD
CY2020Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
230257000 USD
CY2019Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
268894000 USD
CY2020Q3 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
55038000 USD
CY2019Q4 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
55468000 USD
CY2019Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
1649000 USD
CY2020Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
15650000 USD
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
13314000 USD
CY2020Q3 nshi Deferred Costs And Intangible Assets Net
DeferredCostsAndIntangibleAssetsNet
26951000 USD
CY2019Q4 nshi Deferred Costs And Intangible Assets Net
DeferredCostsAndIntangibleAssetsNet
28355000 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
9561000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
14489000 USD
CY2020Q3 us-gaap Assets
Assets
2007962000 USD
CY2019Q4 us-gaap Assets
Assets
2141207000 USD
CY2020Q3 us-gaap Notes Payable
NotesPayable
1421453000 USD
CY2019Q4 us-gaap Notes Payable
NotesPayable
1431922000 USD
CY2020Q3 nshi Line Of Credit Related Party
LineOfCreditRelatedParty
35000000 USD
CY2019Q4 nshi Line Of Credit Related Party
LineOfCreditRelatedParty
0 USD
CY2020Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
3884000 USD
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
5780000 USD
CY2020Q3 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
4429000 USD
CY2019Q4 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
3292000 USD
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
37025000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
28135000 USD
CY2020Q3 us-gaap Other Liabilities
OtherLiabilities
4124000 USD
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
4574000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
1505915000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
1473703000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
1900000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1891000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1707876000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1702260000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1211046000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
497861000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1041297000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-869000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-470000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
662384000 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
4186000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
5120000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
502047000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
667504000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2007962000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2141207000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28006000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
32283000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
90033000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
97658000 USD
CY2020Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
39114000 USD
CY2019Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
40410000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
118309000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
121168000 USD
CY2020Q3 us-gaap Other Operating Income
OtherOperatingIncome
635000 USD
CY2019Q3 us-gaap Other Operating Income
OtherOperatingIncome
85000 USD
us-gaap Other Operating Income
OtherOperatingIncome
1612000 USD
us-gaap Other Operating Income
OtherOperatingIncome
1445000 USD
CY2020Q3 us-gaap Revenues
Revenues
67755000 USD
CY2019Q3 us-gaap Revenues
Revenues
72778000 USD
us-gaap Revenues
Revenues
209954000 USD
us-gaap Revenues
Revenues
220271000 USD
CY2020Q3 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
1927000 USD
CY2019Q3 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
1946000 USD
us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
5738000 USD
us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
5771000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46501000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45359000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
137530000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
135213000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
16459000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
17218000 USD
us-gaap Interest Expense
InterestExpense
49591000 USD
us-gaap Interest Expense
InterestExpense
51908000 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2019Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
29000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
105000 USD
CY2020Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
4431000 USD
CY2019Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
4994000 USD
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
13293000 USD
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
14983000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3446000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2807000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8763000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8210000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
54525000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15945000 USD
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16164000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48929000 USD
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2019Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
91437000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
10146000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
86782000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
86571000 USD
us-gaap Costs And Expenses
CostsAndExpenses
349550000 USD
us-gaap Costs And Expenses
CostsAndExpenses
275090000 USD
CY2020Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
CY2019Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
204000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
5926000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17100000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11643000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-133858000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-43122000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1043000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3037000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-36799000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7666000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-18158000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-14697000 USD
us-gaap Profit Loss
ProfitLoss
-170700000 USD
us-gaap Profit Loss
ProfitLoss
-50826000 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14624000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-171000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-73000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-951000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-439000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17987000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-169749000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-50387000 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.90
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
189756911 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
189094572 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
189378629 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
189061291 shares
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-171099000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-50914000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-14697000 USD
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.03
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-18158000 USD
us-gaap Profit Loss
ProfitLoss
-170700000 USD
us-gaap Profit Loss
ProfitLoss
-50826000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
459000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
786000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-399000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-88000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
459000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
786000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-399000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-88000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-17699000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-13911000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-171000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-73000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-951000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-439000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17528000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13838000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-170148000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50475000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
744374000 USD
CY2019Q1 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
45000 USD
CY2019Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
256000 USD
CY2019Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
72000 USD
CY2019Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1978000 USD
CY2019Q1 us-gaap Dividends Common Stock
DividendsCommonStock
5413000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
4876000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
200000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-18669000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
726119000 USD
CY2019Q2 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
46000 USD
CY2019Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
62000 USD
CY2019Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
67000 USD
CY2019Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
3204000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1074000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-17460000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
706922000 USD
CY2019Q3 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
45000 USD
CY2019Q3 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
112000 USD
CY2019Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
74000 USD
CY2019Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
2234000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
786000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-14697000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
693360000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
667504000 USD
CY2020Q1 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
38000 USD
CY2020Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
86000 USD
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
85000 USD
CY2020Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1998000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1044000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-12547000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
654454000 USD
CY2020Q2 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
39000 USD
CY2020Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
7000 USD
CY2020Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
54000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
186000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-139995000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
517137000 USD
CY2020Q3 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
46000 USD
CY2020Q3 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
75000 USD
CY2020Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
12000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
459000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-18158000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
502047000 USD
us-gaap Profit Loss
ProfitLoss
-170700000 USD
us-gaap Profit Loss
ProfitLoss
-50826000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-36799000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7666000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48929000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
54525000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
91437000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
10146000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
222000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
193000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2311000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2253000 USD
us-gaap Straight Line Rent
StraightLineRent
-224000 USD
us-gaap Straight Line Rent
StraightLineRent
478000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
92000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
83000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1416000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1367000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
123000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
136000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
5926000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1803000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-743000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27980000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
595000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
7500000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
7500000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
4363000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
790000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4961000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
644000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-1896000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-1330000 USD
nshi Increase Decreasein Escrow Payable
IncreaseDecreaseinEscrowPayable
1137000 USD
nshi Increase Decreasein Escrow Payable
IncreaseDecreaseinEscrowPayable
1739000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8274000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5257000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-105000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20043000 USD
nshi Paymentsto Improve Real Estate
PaymentstoImproveRealEstate
8990000 USD
nshi Paymentsto Improve Real Estate
PaymentstoImproveRealEstate
14644000 USD
nshi Proceeds From Sale Of Real Estate Investing
ProceedsFromSaleOfRealEstateInvesting
927000 USD
nshi Proceeds From Sale Of Real Estate Investing
ProceedsFromSaleOfRealEstateInvesting
19618000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
39801000 USD
nshi Proceedsfrom Equity Method Investment Dividendsor Distributions Financing Activities
ProceedsfromEquityMethodInvestmentDividendsorDistributionsFinancingActivities
1963000 USD
nshi Proceedsfrom Equity Method Investment Dividendsor Distributions Financing Activities
ProceedsfromEquityMethodInvestmentDividendsorDistributionsFinancingActivities
16846000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
35000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-934000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6135000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17047000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
12800000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
14418000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
45868000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
708000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
457000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
35000000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
424000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1998000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7416000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10813000 USD
us-gaap Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan
ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan
0 USD
us-gaap Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan
ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan
4876000 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
168000 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
430000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
151000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
213000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18144000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-47336000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
39989000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-44340000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58820000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94508000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98809000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50168000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
616000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
835000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
112000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 USD
us-gaap Nature Of Operations
NatureOfOperations
Business and Organization<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the “Company”), was formed to acquire, originate and asset manage a diversified portfolio of equity, debt and securities investments in healthcare real estate, directly or through joint ventures, with a focus on the mid-acuity senior housing sector, which the Company defines as assisted living (“ALF”), memory care (“MCF”), skilled nursing (“SNF”), independent living (“ILF”) facilities and continuing care retirement communities (“CCRC”), which may have independent living, assisted living, skilled nursing and memory care available on one campus. The Company also invests in other healthcare property types, including medical office buildings (“MOB”), hospitals, rehabilitation facilities and ancillary healthcare services businesses. The Company’s investments are predominantly in the United States, but it also selectively makes international investments. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company conducts its operations so as to continue to qualify as a REIT for U.S. federal income tax purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC (the “Prior Advisor”) and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”), each an affiliate of the Company’s sponsor. The Prior Advisor invested $1,000 in the Operating Partnership in exchange for common units and the Special Unit Holder invested $1,000 in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of September 30, 2020 and December 31, 2019. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of September 30, 2020, the Company’s limited partnership interest in the Operating Partnership was 99.99%.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s charter authorizes the issuance of up to 400.0 million shares of common stock with a par value of $0.01 per share and up to 50.0 million shares of preferred stock with a par value of $0.01 per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed its initial public offering (the “Initial Offering”) on February 2, 2015 by raising gross proceeds of $1.1 billion, including 108.6 million shares issued in its initial primary offering (the “Initial Primary Offering”) and 2.0 million shares issued pursuant to its distribution reinvestment plan (the “DRP”). In addition, the Company completed its follow-on offering (the “Follow-On Offering”) on January 19, 2016 by raising gross proceeds of $700.0 million, including 64.9 million shares issued in its follow-on primary offering (the “Follow-on Primary Offering”) and 4.2 million shares issued pursuant to the DRP. The Company refers to its Initial Primary Offering and its Follow-on Primary Offering collectively as the “Primary Offering” and its Initial Offering and Follow-On Offering collectively as the “Offering.” In December 2015, the Company registered an additional 30.0 million shares to be offered pursuant to the DRP. From inception through September 30, 2020, the Company raised total gross proceeds of $2.0 billion, including $232.6 million in DRP proceeds.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is externally managed and has no employees. The Company is sponsored by Colony Capital, Inc. (NYSE: CLNY) (“Colony Capital” or the “Sponsor”), which was formed as a result of the mergers of NorthStar Asset Management Group Inc.(“NSAM”), its prior sponsor, with Colony Capital, Inc. (“Colony”) and NorthStar Realty Finance Corp. (“NorthStar Realty”) in January 2017. Effective June 25, 2018, the Sponsor changed its name from Colony NorthStar, Inc. to Colony Capital, Inc. and its ticker symbol from “CLNS” to “CLNY.” Following the mergers, the Sponsor became an internally-managed equity REIT, with a diversified real estate and investment management platform. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Colony Capital manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds, non-traded and traded REITs and registered investment companies. The Company’s advisor, CNI NSHC Advisors, LLC (the “Advisor”), is a subsidiary of Colony Capital and manages its day-to-day operations pursuant to an advisory agreement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time of preparation of the third quarter 2020 financial statements, the world is continuing to face a global pandemic, the coronavirus 2019 (“COVID-19”). Efforts to address the pandemic continue to significantly impact economic and financial markets globally and across all facets of industries, including real estate. Specifically, the Company's healthcare real estate </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business and investments have experienced a myriad of challenges, including, but not limited to, declines in resident occupancy and operating cash flows, increases in cost burden faced by operators, lease concessions sought by tenants, and a stressed market affecting real estate values in general. Most of these COVID-19 effects on the Company's business significantly impacted results of operations beginning with the three months ended June 30, 2020, and continuing through the three months ended September 30, 2020. At this time, the Company anticipates these pronounced and significant effects to be sustained and continue in future periods. While the Company itself has the ability to meet its near term liquidity needs, general market concerns over credit and liquidity continue to permeate in an economic downturn environment. The effects of COVID-19 may also lead to heightened risk of litigation at the investment and corporate level, with an ensuing increase in litigation and related costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a general economic downturn resulting from efforts to contain COVID-19 persists over an extended period of time, this could have a prolonged negative impact on the Company's financial condition and results of operations. At this time, as the extent and duration of the increasingly broad effects of COVID-19 on the global economy remain unclear, it is difficult for the Company to assess and estimate the impact on the Company's results of operations with any meaningful precision. Accordingly, any estimates of the effects of COVID-19 as reflected and or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Quarterly Report on Form 10-Q, and such estimates may change, the effects of which could be material. The Company will continue to monitor the progression of COVID-19 and reassess its effects on the Company’s results of operations and recoverability in value across its assets as conditions change.</span></div>
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000.0 shares
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000.0 shares
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
1100000000 USD
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
108600000 shares
CY2016Q1 nshi Followon Public Offering
FollowonPublicOffering
700000000.0 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2000000000.0 USD
CY2020Q3 dei Entity Number Of Employees
EntityNumberOfEmployees
0 employee
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
ReclassificationsCertain prior period amounts have been reclassified on the consolidated statements of cash flows from the supplemental disclosure of non-cash investing and financing activities to adjustments to reconcile net income (loss) to net cash provided by operating activities to conform to current period presentation. Further, federal COVID-19 provider relief funds, which totaled $0.8 million for the three months ended June 30, 2020 and presented as resident fee income have been reclassified to other revenue on the consolidated statements of operations during the three months ended September 30, 2020.
CY2020Q2 nshi Federal Covid19 Provider Relief Funds
FederalCOVID19ProviderReliefFunds
800000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions.</span></div>
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72305000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41884000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
26504000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
16936000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98809000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58820000 USD
CY2020Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
3500000 USD
nshi Finance Lease Payments
FinanceLeasePayments
500000 USD
nshi Finance Lease Payments
FinanceLeasePayments
500000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
174000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
670000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
577000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
155000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
59000 USD
CY2020Q3 nshi Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
26000 USD
CY2020Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1661000 USD
CY2020Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
135000 USD
CY2020Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
1526000 USD
CY2020Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.062
CY2020Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M6D
CY2020Q2 us-gaap Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount
ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
0.05
CY2020Q3 us-gaap Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount
ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
0.05
CY2020Q3 us-gaap Finite Lived Intangible Asset Acquired In Place Leases
FiniteLivedIntangibleAssetAcquiredInPlaceLeases
5086000 USD
CY2019Q4 us-gaap Finite Lived Intangible Asset Acquired In Place Leases
FiniteLivedIntangibleAssetAcquiredInPlaceLeases
6437000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
21387000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
21387000 USD
CY2020Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
380000 USD
CY2019Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
380000 USD
CY2020Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
26853000 USD
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
28204000 USD
CY2020Q3 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
98000 USD
CY2019Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
151000 USD
CY2020Q3 nshi Deferred Costs And Intangible Assets Net
DeferredCostsAndIntangibleAssetsNet
26951000 USD
CY2019Q4 nshi Deferred Costs And Intangible Assets Net
DeferredCostsAndIntangibleAssetsNet
28355000 USD
nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
1400000 USD
nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
7800000 USD
CY2020Q3 nshi Deferred Costsand Finite Lived Intangible Assets Amortization Expense Remainderof Fiscal Year
DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseRemainderofFiscalYear
468000 USD
CY2020Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year One
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearOne
1871000 USD
CY2020Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Two
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
593000 USD
CY2020Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Three
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearThree
337000 USD
CY2020Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Four
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearFour
337000 USD
CY2020Q3 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense After Year Four
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
1578000 USD
CY2020Q3 nshi Deferred Costsand Finite Lived Intangible Assets Net
DeferredCostsandFiniteLivedIntangibleAssetsNet
5184000 USD
CY2020Q3 nshi Acquisition Feeand Expense Cap
AcquisitionFeeandExpenseCap
0.060
CY2020Q3 nshi Healthcare Facility Regulatory Reserve
HealthcareFacilityRegulatoryReserve
0 USD
CY2019Q4 nshi Healthcare Facility Regulatory Reserve
HealthcareFacilityRegulatoryReserve
6000000 USD
CY2020Q3 nshi Ownership Interestin Condominiums
OwnershipInterestinCondominiums
2327000 USD
CY2019Q4 nshi Ownership Interestin Condominiums
OwnershipInterestinCondominiums
2327000 USD
CY2020Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
4547000 USD
CY2019Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
3841000 USD
CY2020Q3 us-gaap Lease Incentive Receivable
LeaseIncentiveReceivable
2065000 USD
CY2019Q4 us-gaap Lease Incentive Receivable
LeaseIncentiveReceivable
1636000 USD
CY2020Q3 nshi Utility Deposit Assets
UtilityDepositAssets
314000 USD
CY2019Q4 nshi Utility Deposit Assets
UtilityDepositAssets
317000 USD
CY2020Q3 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
308000 USD
CY2019Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
368000 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
9561000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
14489000 USD
CY2020Q3 nshi Lease Terms Days Notice Required For Termination
LeaseTermsDaysNoticeRequiredForTermination
30 D
CY2020Q3 nshi Lease Terms Days Notice Required For Termination
LeaseTermsDaysNoticeRequiredForTermination
30 D
CY2020Q3 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
2600000 USD
CY2019Q3 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
4200000 USD
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
10900000 USD
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
12300000 USD
CY2020Q3 nshi Federal Covid19 Provider Relief Funds
FederalCOVID19ProviderReliefFunds
600000 USD
nshi Federal Covid19 Provider Relief Funds
FederalCOVID19ProviderReliefFunds
1400000 USD
nshi Lessor Concession Granted Period Covid19
LessorConcessionGrantedPeriodCOVID19
P90D
nshi Lessor Concession Granted Repayment Period Covid19
LessorConcessionGrantedRepaymentPeriodCOVID19
P12M
CY2020Q3 nshi Lessor Concession Granted Payments Deferred Covid19
LessorConcessionGrantedPaymentsDeferredCOVID19
3900000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
91400000 USD
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 USD
nshi Impairment Of Affiliate Properties
ImpairmentOfAffiliateProperties
37800000 USD
CY2020Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
20200000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000 USD
CY2020Q3 us-gaap Land
Land
236036000 USD
CY2019Q4 us-gaap Land
Land
236036000 USD
CY2020Q3 us-gaap Land Improvements
LandImprovements
23700000 USD
CY2019Q4 us-gaap Land Improvements
LandImprovements
23287000 USD
CY2020Q3 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1466252000 USD
CY2019Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1551113000 USD
CY2020Q3 us-gaap Tenant Improvements
TenantImprovements
16041000 USD
CY2019Q4 us-gaap Tenant Improvements
TenantImprovements
14642000 USD
CY2020Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1593000 USD
CY2019Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
4956000 USD
CY2020Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
106408000 USD
CY2019Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
100998000 USD
CY2020Q3 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1850030000 USD
CY2019Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1931032000 USD
CY2020Q3 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
278334000 USD
CY2019Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
230814000 USD
CY2020Q3 us-gaap Real Estate Investments
RealEstateInvestments
1571696000 USD
CY2019Q4 us-gaap Real Estate Investments
RealEstateInvestments
1700218000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
15500000 USD
us-gaap Depreciation
Depreciation
47500000 USD
CY2019Q3 us-gaap Depreciation
Depreciation
15700000 USD
us-gaap Depreciation
Depreciation
46800000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
91400000 USD
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
10100000 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
230257000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
268894000 USD
CY2019Q1 nshi Equity Method Investment Numberof Facilities Sold
EquityMethodInvestmentNumberofFacilitiesSold
11 facility
CY2019Q1 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
118000000.0 USD
CY2019Q1 nshi Proceeds From Sale Of Property Held For Sale Net
ProceedsFromSaleOfPropertyHeldForSaleNet
4300000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1043000 USD
CY2020Q3 nshi Equity Method Investment Select Revenuesand Expenses Net
EquityMethodInvestmentSelectRevenuesandExpensesNet
-8602000 USD
CY2020Q3 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
198000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3037000 USD
CY2019Q3 nshi Equity Method Investment Select Revenuesand Expenses Net
EquityMethodInvestmentSelectRevenuesandExpensesNet
-11534000 USD
CY2019Q3 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4767000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-36799000 USD
nshi Equity Method Investment Select Revenuesand Expenses Net
EquityMethodInvestmentSelectRevenuesandExpensesNet
-67770000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1963000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7666000 USD
nshi Equity Method Investment Select Revenuesand Expenses Net
EquityMethodInvestmentSelectRevenuesandExpensesNet
-34027000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
16846000 USD
CY2019Q1 nshi Equity Method Investment Numberof Facilities Sold
EquityMethodInvestmentNumberofFacilitiesSold
11 facility
CY2019Q1 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
118000000.0 USD
CY2019Q1 nshi Proceeds From Sale Of Property Held For Sale Net
ProceedsFromSaleOfPropertyHeldForSaleNet
4300000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
9377000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
76127000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
466725000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
19056000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
19778000 USD
CY2020Q3 nshi Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
850155000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
1441218000 USD
CY2020Q2 nshi Debt Forbearance Period Maximum
DebtForbearancePeriodMaximum
P90D
CY2020Q3 nshi Debt Instrument Principal Deferred Covid19
DebtInstrumentPrincipalDeferredCOVID19
1300000000 USD
nshi Debt Forbearance Repayment Period
DebtForbearanceRepaymentPeriod
P12M
nshi Debt Forbearance Repayment Period
DebtForbearanceRepaymentPeriod
P12M
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
5780000 USD
nshi Related Party Transaction Dueto Related Parties Amount Incurred
RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred
20580000 USD
nshi Related Party Transaction Dueto Related Parties Amount Paid
RelatedPartyTransactionDuetoRelatedPartiesAmountPaid
22476000 USD
CY2020Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
3884000 USD
nshi Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees
NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees
7500000 USD
nshi Stock Redeemedor Called During Period Shares Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodSharesPaymentofAdvisorAssetManagementFees
1200000 shares
nshi Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees
NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees
7500000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45625 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
123292 USD
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
6.25
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
135500 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
200000 USD
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
200000 USD
nshi Common Stock Dividend Declared Based On Daily Amount Per Share
CommonStockDividendDeclaredBasedOnDailyAmountPerShare
0.00184932
nshi Common Stock Annualized Distribution
CommonStockAnnualizedDistribution
0.675
CY2018 nshi Common Stock Dividend Declared Based On Daily Amount Per Share
CommonStockDividendDeclaredBasedOnDailyAmountPerShare
0.000924658
CY2018 nshi Common Stock Annualized Distribution
CommonStockAnnualizedDistribution
0.3375
CY2019Q1 nshi Common Stock Dividend Declared Based On Daily Amount Per Share
CommonStockDividendDeclaredBasedOnDailyAmountPerShare
0.000924658
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
86000000.0 USD
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
300000 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2000000.0 USD
CY2019 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1500000 shares
CY2019 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10700000 USD
CY2019 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
7.10
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-200000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000000.0 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-100000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-400000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
5 segment
CY2020Q3 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
75 property
CY2020Q3 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
10515 unit
us-gaap Noninterest Income
NoninterestIncome
209954000 USD
CY2020Q3 nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
67755000 USD
CY2020Q3 us-gaap Interest Income Operating
InterestIncomeOperating
1927000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46501000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
16459000 USD
CY2020Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
4431000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3446000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15945000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1043000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-18158000 USD
CY2019Q3 nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
72778000 USD
CY2019Q3 us-gaap Interest Income Operating
InterestIncomeOperating
1946000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45359000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
17218000 USD
CY2019Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
29000 USD
CY2019Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
4994000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2807000 USD
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16164000 USD
CY2019Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
204000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3037000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-14697000 USD
nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
209954000 USD
us-gaap Interest Income Operating
InterestIncomeOperating
5738000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
137530000 USD
us-gaap Interest Expense
InterestExpense
49591000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7000 USD
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
13293000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8763000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48929000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
91437000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000 USD
us-gaap Profit Loss
ProfitLoss
-170700000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-36799000 USD
CY2020Q3 us-gaap Assets
Assets
2007962000 USD
nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
220271000 USD
us-gaap Interest Income Operating
InterestIncomeOperating
5771000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
135213000 USD
us-gaap Interest Expense
InterestExpense
51908000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
105000 USD
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
14983000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8210000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
54525000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
10146000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
5926000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7666000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000 USD
us-gaap Profit Loss
ProfitLoss
-50826000 USD
CY2019Q4 us-gaap Assets
Assets
2141207000 USD

Files In Submission

Name View Source Status
0001503707-20-000033-index-headers.html Edgar Link pending
0001503707-20-000033-index.html Edgar Link pending
0001503707-20-000033.txt Edgar Link pending
0001503707-20-000033-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nshi-20200930.htm Edgar Link pending
nshi-20200930.xsd Edgar Link pending
nshi-20200930_cal.xml Edgar Link unprocessable
nshi-20200930_def.xml Edgar Link unprocessable
nshi-20200930_g1.jpg Edgar Link pending
nshi-20200930_g2.jpg Edgar Link pending
nshi-20200930_htm.xml Edgar Link completed
nshi-20200930_lab.xml Edgar Link unprocessable
nshi-20200930_pre.xml Edgar Link unprocessable
nshi09302020exhibit311.htm Edgar Link pending
nshi09302020exhibit312.htm Edgar Link pending
nshi09302020exhibit321.htm Edgar Link pending
nshi09302020exhibit322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending